JP2005518418A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005518418A5 JP2005518418A5 JP2003563517A JP2003563517A JP2005518418A5 JP 2005518418 A5 JP2005518418 A5 JP 2005518418A5 JP 2003563517 A JP2003563517 A JP 2003563517A JP 2003563517 A JP2003563517 A JP 2003563517A JP 2005518418 A5 JP2005518418 A5 JP 2005518418A5
- Authority
- JP
- Japan
- Prior art keywords
- osmotic
- tablet according
- acid
- osmotic tablet
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000003204 osmotic effect Effects 0.000 claims 24
- 239000003826 tablet Substances 0.000 claims 22
- 239000003814 drug Substances 0.000 claims 7
- 229940079593 drug Drugs 0.000 claims 7
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims 4
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims 4
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims 4
- 230000001105 regulatory effect Effects 0.000 claims 4
- 239000000126 substance Substances 0.000 claims 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 claims 2
- 230000032683 aging Effects 0.000 claims 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims 2
- 239000010410 layer Substances 0.000 claims 2
- 239000002590 phosphodiesterase V inhibitor Substances 0.000 claims 2
- 230000005070 ripening Effects 0.000 claims 2
- BNRNXUUZRGQAQC-UHFFFAOYSA-N sildenafil Chemical compound CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 BNRNXUUZRGQAQC-UHFFFAOYSA-N 0.000 claims 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 claims 1
- 239000005711 Benzoic acid Substances 0.000 claims 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims 1
- 239000001361 adipic acid Substances 0.000 claims 1
- 235000011037 adipic acid Nutrition 0.000 claims 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims 1
- 239000011668 ascorbic acid Substances 0.000 claims 1
- 235000010323 ascorbic acid Nutrition 0.000 claims 1
- 229960005070 ascorbic acid Drugs 0.000 claims 1
- 235000010233 benzoic acid Nutrition 0.000 claims 1
- 239000007894 caplet Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 235000015165 citric acid Nutrition 0.000 claims 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 239000001530 fumaric acid Substances 0.000 claims 1
- 235000011087 fumaric acid Nutrition 0.000 claims 1
- 235000013922 glutamic acid Nutrition 0.000 claims 1
- 239000004220 glutamic acid Substances 0.000 claims 1
- 239000001630 malic acid Substances 0.000 claims 1
- 235000011090 malic acid Nutrition 0.000 claims 1
- 239000003002 pH adjusting agent Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 229960003310 sildenafil Drugs 0.000 claims 1
- 239000002356 single layer Substances 0.000 claims 1
- 239000004334 sorbic acid Substances 0.000 claims 1
- 235000010199 sorbic acid Nutrition 0.000 claims 1
- 229940075582 sorbic acid Drugs 0.000 claims 1
- 239000000600 sorbitol Substances 0.000 claims 1
- 235000002906 tartaric acid Nutrition 0.000 claims 1
- 239000011975 tartaric acid Substances 0.000 claims 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35315102P | 2002-02-01 | 2002-02-01 | |
| US60/353,151 | 2002-02-01 | ||
| PCT/IB2003/000265 WO2003063823A2 (en) | 2002-02-01 | 2003-01-28 | Osmotic delivery system |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005518418A JP2005518418A (ja) | 2005-06-23 |
| JP2005518418A5 true JP2005518418A5 (https=) | 2006-01-05 |
Family
ID=27663182
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003563517A Abandoned JP2005518418A (ja) | 2002-02-01 | 2003-01-28 | 浸透圧による送達システム |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20030175346A1 (https=) |
| EP (1) | EP1469826B1 (https=) |
| JP (1) | JP2005518418A (https=) |
| KR (1) | KR20040083492A (https=) |
| CN (1) | CN1625388A (https=) |
| AR (1) | AR038373A1 (https=) |
| AT (1) | ATE345776T1 (https=) |
| BR (1) | BR0307320A (https=) |
| CA (1) | CA2474425A1 (https=) |
| DE (1) | DE60309832T2 (https=) |
| ES (1) | ES2277632T3 (https=) |
| GT (1) | GT200300017A (https=) |
| MX (1) | MXPA04007437A (https=) |
| NO (1) | NO20043646L (https=) |
| NZ (1) | NZ533986A (https=) |
| PA (1) | PA8565201A1 (https=) |
| PE (1) | PE20030801A1 (https=) |
| PL (1) | PL372172A1 (https=) |
| RU (1) | RU2004123623A (https=) |
| TW (1) | TW200302748A (https=) |
| UY (1) | UY27644A1 (https=) |
| WO (1) | WO2003063823A2 (https=) |
| ZA (1) | ZA200405406B (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0203296D0 (en) | 2002-02-12 | 2002-03-27 | Glaxo Group Ltd | Novel composition |
| US8637512B2 (en) | 2002-07-29 | 2014-01-28 | Glaxo Group Limited | Formulations and method of treatment |
| US7829507B2 (en) * | 2003-09-17 | 2010-11-09 | Halliburton Energy Services Inc. | Subterranean treatment fluids comprising a degradable bridging agent and methods of treating subterranean formations |
| ATE521343T1 (de) * | 2004-11-24 | 2011-09-15 | Teva Pharma | Im mund zerfallende zusammensetzungen von rasagilin |
| GB2421431B (en) * | 2004-12-24 | 2007-10-10 | Aquasol Ltd | Dosing systems |
| WO2006072878A1 (en) * | 2005-01-07 | 2006-07-13 | Ranbaxy Laboratories Limited | Oral dosage forms of sertraline having controlled particle size and processes for their preparation |
| DE102005009240A1 (de) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften |
| US8637080B2 (en) * | 2007-06-28 | 2014-01-28 | Osmotica Kereskedelmi és Szolgáltató, KFT | Rupturing controlled release device comprising a subcoat |
| RU2589823C2 (ru) * | 2009-04-09 | 2016-07-10 | Алкермес Фарма Айэленд Лимитед | Композиция для доставки лекарственных средств |
| SMT202000093T1 (it) | 2009-06-16 | 2020-03-13 | Pfizer | Forme di dosaggio di apixaban |
| IT1399240B1 (it) * | 2010-03-22 | 2013-04-11 | Trere Chimica S A S | Metodo e prodotto per il trattamento di sostanze alcooliche, mosti d'uva e derivati |
| CN102379858B (zh) * | 2011-10-12 | 2013-06-19 | 中国药科大学 | 一种可装载大剂量难溶性药物并促进其吸收的渗透泵片 |
| JP6041823B2 (ja) | 2013-03-16 | 2016-12-14 | ファイザー・インク | トファシチニブの経口持続放出剤形 |
| KR102546286B1 (ko) * | 2019-11-08 | 2023-06-22 | 씨제이제일제당 (주) | 눌은 식감을 갖는 전자레인지 조리용 냉동 포장밥 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US64556A (en) * | 1867-05-07 | Improved belt-punch | ||
| US143272A (en) * | 1873-09-30 | Improvement in saw-sets | ||
| US39691A (en) * | 1863-08-25 | Improvement in pipe-couplings | ||
| US3845770A (en) * | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US3916899A (en) * | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
| US4036228A (en) * | 1975-09-11 | 1977-07-19 | Alza Corporation | Osmotic dispenser with gas generating means |
| US4077407A (en) * | 1975-11-24 | 1978-03-07 | Alza Corporation | Osmotic devices having composite walls |
| US4111202A (en) * | 1976-11-22 | 1978-09-05 | Alza Corporation | Osmotic system for the controlled and delivery of agent over time |
| US4265874A (en) * | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
| US4327725A (en) * | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
| US4732915A (en) * | 1983-11-02 | 1988-03-22 | Alza Corporation | Process for increasing solubility of drug |
| US4610686A (en) * | 1983-11-02 | 1986-09-09 | Alza Corporation | Controlled delivery of haloperidol by an osmotic delivery system |
| US4627850A (en) * | 1983-11-02 | 1986-12-09 | Alza Corporation | Osmotic capsule |
| US4627971A (en) * | 1985-04-22 | 1986-12-09 | Alza Corporation | Osmotic device with self-sealing passageway |
| CH668187A5 (de) * | 1986-08-07 | 1988-12-15 | Ciba Geigy Ag | Therapeutisches system mit systemischer wirkung. |
| US5108756A (en) * | 1989-01-12 | 1992-04-28 | Pfizer Inc. | Dispensing devices powered by lyotropic liquid crystals |
| US5071607A (en) * | 1990-01-31 | 1991-12-10 | Alza Corporatino | Method and apparatus for forming a hole in a drug dispensing device |
| US5284662A (en) * | 1990-10-01 | 1994-02-08 | Ciba-Geigy Corp. | Oral osmotic system for slightly soluble active agents |
| US5869097A (en) * | 1992-11-02 | 1999-02-09 | Alza Corporation | Method of therapy comprising an osmotic caplet |
| HU213407B (en) * | 1993-12-09 | 1997-06-30 | Egyt Gyogyszervegyeszeti Gyar | Process for producing tablet with diffusive-osmotic release |
| US5698224A (en) * | 1994-06-27 | 1997-12-16 | Alza Corporation | Tacrine therapy |
| US5736159A (en) * | 1995-04-28 | 1998-04-07 | Andrx Pharmaceuticals, Inc. | Controlled release formulation for water insoluble drugs in which a passageway is formed in situ |
| US5654005A (en) * | 1995-06-07 | 1997-08-05 | Andrx Pharmaceuticals, Inc. | Controlled release formulation having a preformed passageway |
| US6361796B1 (en) * | 1996-10-25 | 2002-03-26 | Shire Laboratories, Inc. | Soluble form osmotic dose delivery system |
| ATE314054T1 (de) * | 1996-10-25 | 2006-01-15 | Shire Lab Inc | Osmotisches verabreichungssystem für lösliche dosen |
| US5837379A (en) * | 1997-01-31 | 1998-11-17 | Andrx Pharmaceuticals, Inc. | Once daily pharmaceutical tablet having a unitary core |
| US6485748B1 (en) * | 1997-12-12 | 2002-11-26 | Andrx Pharmaceuticals, Inc. | Once daily pharmaceutical tablet having a unitary core |
| US6224907B1 (en) * | 1998-03-06 | 2001-05-01 | Alza Corporation | Anti-asthma therapy |
| US6099859A (en) * | 1998-03-20 | 2000-08-08 | Andrx Pharmaceuticals, Inc. | Controlled release oral tablet having a unitary core |
| US6156342A (en) * | 1998-05-26 | 2000-12-05 | Andex Pharmaceuticals, Inc. | Controlled release oral dosage form |
| US20010031279A1 (en) * | 1998-11-02 | 2001-10-18 | Evangeline Cruz | Controlled delivery of antidepressants |
| JP2000171868A (ja) * | 1998-12-08 | 2000-06-23 | Canon Inc | フィルム送り装置、フィルム使用装置および光学機器 |
| US6706283B1 (en) * | 1999-02-10 | 2004-03-16 | Pfizer Inc | Controlled release by extrusion of solid amorphous dispersions of drugs |
| US6352721B1 (en) * | 2000-01-14 | 2002-03-05 | Osmotica Corp. | Combined diffusion/osmotic pumping drug delivery system |
| AR026148A1 (es) * | 2000-01-21 | 2003-01-29 | Osmotica Argentina S A | Dispositivo osmotico con pasaje preformado que aumenta de tamano |
| WO2001091716A1 (en) * | 2000-05-30 | 2001-12-06 | Add Advanced Drug Delivery Technologies Ag | Peroral therapeutic system comprising glipizide |
| IN190699B (https=) * | 2001-02-02 | 2003-08-16 | Sun Pharmaceutical Ind Ltd | |
| US20030185882A1 (en) * | 2001-11-06 | 2003-10-02 | Vergez Juan A. | Pharmaceutical compositions containing oxybutynin |
-
2003
- 2003-01-27 US US10/352,283 patent/US20030175346A1/en not_active Abandoned
- 2003-01-27 TW TW092101714A patent/TW200302748A/zh unknown
- 2003-01-28 JP JP2003563517A patent/JP2005518418A/ja not_active Abandoned
- 2003-01-28 EP EP03701640A patent/EP1469826B1/en not_active Expired - Lifetime
- 2003-01-28 CA CA002474425A patent/CA2474425A1/en not_active Abandoned
- 2003-01-28 DE DE60309832T patent/DE60309832T2/de not_active Expired - Lifetime
- 2003-01-28 NZ NZ533986A patent/NZ533986A/xx unknown
- 2003-01-28 ES ES03701640T patent/ES2277632T3/es not_active Expired - Lifetime
- 2003-01-28 BR BR0307320-3A patent/BR0307320A/pt not_active IP Right Cessation
- 2003-01-28 MX MXPA04007437A patent/MXPA04007437A/es unknown
- 2003-01-28 KR KR10-2004-7011821A patent/KR20040083492A/ko not_active Abandoned
- 2003-01-28 RU RU2004123623/15A patent/RU2004123623A/ru not_active Application Discontinuation
- 2003-01-28 AT AT03701640T patent/ATE345776T1/de not_active IP Right Cessation
- 2003-01-28 WO PCT/IB2003/000265 patent/WO2003063823A2/en not_active Ceased
- 2003-01-28 CN CNA038031213A patent/CN1625388A/zh active Pending
- 2003-01-28 PL PL03372172A patent/PL372172A1/xx unknown
- 2003-01-29 GT GT200300017A patent/GT200300017A/es unknown
- 2003-01-30 AR ARP030100272A patent/AR038373A1/es unknown
- 2003-01-30 PE PE2003000100A patent/PE20030801A1/es not_active Application Discontinuation
- 2003-01-31 UY UY27644A patent/UY27644A1/es not_active Application Discontinuation
- 2003-02-03 PA PA20038565201A patent/PA8565201A1/es unknown
-
2004
- 2004-07-07 ZA ZA200405406A patent/ZA200405406B/en unknown
- 2004-08-31 NO NO20043646A patent/NO20043646L/no unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005518418A5 (https=) | ||
| JP2004538301A5 (https=) | ||
| RU2003138075A (ru) | Удерживаемая в желудке система регулируемой доставки лекарственного средства | |
| KR101715008B1 (ko) | Ｌ―오르니틴 페닐아세테이트를 사용한 문맥압 항진증의 치료 및 간 기능 회복 | |
| JP5166018B2 (ja) | 胃貯留系 | |
| RU2004123623A (ru) | Системы осмотической доставки | |
| JP2010529018A5 (ja) | 医薬組成物、および医薬錠剤 | |
| TWI302460B (en) | Pharmaceutical compositions and use thereof | |
| JP2006520797A5 (https=) | ||
| JP2007501248A5 (https=) | ||
| EP2374479A2 (en) | Controlled-release composition for producing sustained-release preparation containing udenafil | |
| JP2006512286A5 (https=) | ||
| RU2008127882A (ru) | Лечение пищевода барретта | |
| JP2009155312A5 (https=) | ||
| CN101146521A (zh) | 提供包含纤维素和甲基丙烯酸衍生物包衣的口服药物输送系统 | |
| JP4956981B2 (ja) | オキシメタゾリン含有水性組成物 | |
| JP2007522223A5 (https=) | ||
| CN102935074B (zh) | 一种盐酸曲唑酮渗透泵控释片 | |
| EP1795207A1 (en) | Solid pharmaceutical preparation | |
| CN102144985B (zh) | 一种氯化钾单室渗透泵控释片及其制备方法 | |
| FI4081187T3 (fi) | Ibuprofeenia ja fenyyliefriiniä käsittävä nestemäinen koostumus | |
| CN107929253A (zh) | 一种单硝酸异山梨酯渗透泵控释片及其制备方法 | |
| MX2009000923A (es) | Metodos para tratar cuando menos una condicion que tiene receptor de mt1, receptor de 5ht2b, y actividad de canal de calcio tipo l. | |
| WO2003075919A1 (fr) | Comprime contenant du chlorhydrate de pilsicainide (voie seche) | |
| JP5123471B2 (ja) | 用量調整が容易な製剤 |